Khawaja M Talha

Apr 1, 2024 | dom-pubs.onlinelibrary.wiley.com | Khawaja M Talha |Jennifer Green |Gerasimos Filippatos |Stuart J. Pocock

CONFLICT OF INTEREST STATEMENT KMT has no conflicts of interest to declare. JG reports personal fees from Boehringer Ingelheim, Lilly, Bayer, Novo Nordisk, Pfizer, AstraZeneca, Sanofi, Hawthorne Effect, Omada Health, Vertex Pharmaceuticals, Valo Therapeutics and Anji Pharmaceuticals; receiving grants from Merck, Roche, Sanofi and Lexicon Pharmaceuticals.

Feb 20, 2024 | onlinelibrary.wiley.com | Khawaja M Talha |James L. Januzzi |Stephen Greene |Muthiah Vaduganathan

Supporting Information Filename Description ejhf3165-sup-0001-Tables.docxWord 2007 document , 39.9 KB Table S1. Baseline characteristics for symptom analysis in patients with first diagnosis of heart failure. Table S2: Diasgnostic codes used for assessment clinical co-morbidities in heart failure patients included in this study. Table S3: Baseline characteristics of patients with incident heart failure diagnosis stratified by echocardiography testing status.

Aug 16, 2023 | onlinelibrary.wiley.com | Khawaja M Talha |Ambarish Pandey |Marat Fudim |Javed Butler

Introduction Frailty is defined as a decline in an individual's physical and cognitive reserve that prohibits regulatory bodily mechanisms to counter or recover from an acute stressor driven by the amplification of inflammatory mechanisms and sarcopenia among other causes.